EU Reallocates UK’s Centrally Authorized Medical Product Portfolio

Drug Industry Daily
A A
The EU reassigned oversight of more than 370 centrally authorized drugs from UK agencies to other EU member states in anticipation of Brexit.

To View This Article:

Login

Subscribe To Drug Industry Daily